VSee Health, Inc. (NASDAQ:VSEE – Get Free Report) dropped 0.5% on Monday. The stock traded as low as $1.6579 and last traded at $1.88. Approximately 3,497 shares traded hands during trading, a decline of 100% from the average daily volume of 3,644,416 shares. The stock had previously closed at $1.89.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of VSee Health in a research note on Friday, July 17th. One investment analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company currently has a consensus rating of “Sell”.
Get Our Latest Analysis on VSee Health
VSee Health Price Performance
The firm’s fifty day simple moving average is $1.75 and its 200-day simple moving average is $8.39. The company has a quick ratio of 0.41, a current ratio of 0.41 and a debt-to-equity ratio of 0.12. The firm has a market capitalization of $6.66 million and a PE ratio of -3.43.
About VSee Health
VSee Health, Inc (NASDAQ: VSEE) is a healthcare technology and virtual-care company that provides telehealth solutions for healthcare organizations, clinicians, and patients. Its platform supports secure video visits, digital patient engagement, clinical communication, and the delivery of remote medical services.
The company’s products and services are designed to support a range of care models, including virtual clinics, remote patient monitoring, tele-intensive care, emergency and specialty consultations, and other distributed-care programs.
Further Reading
- Five stocks we like better than VSee Health
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for VSee Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VSee Health and related companies with MarketBeat.com's FREE daily email newsletter.
